Company Filing History:
3 out of 3,539 
3 out of 712 
3 out of 270 
Years Active: 2015-2017
Title: Innovations of Joshua McCoy
Introduction
Joshua McCoy is an accomplished inventor based in Portland, ME (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating thrombotic disorders. With a total of 3 patents to his name, McCoy's work has the potential to impact the medical community significantly.
Latest Patents
Among his latest patents, McCoy has developed compounds such as Oxadiazolo[3,2-A]pyrimidines and thiadiazolo[3,2-A]pyrimidines. These inventions relate to compounds of Formula P-I, which are designed to inhibit and/or reduce platelet deposition, adhesion, and aggregation. The inventions also encompass methods for treating or preventing thrombotic disorders, including stroke, myocardial infarction, unstable angina, peripheral vascular disease, and complications following angioplasty or stent placement. Another notable patent includes 7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones, which similarly focuses on inhibiting platelet-related issues and outlines methods for treating thrombotic disorders.
Career Highlights
Joshua McCoy has worked with prestigious organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and The Rockefeller University. His experience in these institutions has provided him with a solid foundation in research and development, allowing him to innovate effectively in his field.
Collaborations
Throughout his career, McCoy has collaborated with notable colleagues, including Barry S. Coller and Craig J. Thomas. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Joshua McCoy's innovative work in the field of medicinal chemistry showcases his dedication to addressing critical health issues through his inventions. His patents reflect a commitment to improving treatment options for thrombotic disorders, making him a significant figure in the realm of medical research and innovation.